Genetic mutations or alterations in TSC1/2 have an important role not only in various cancers but also in some slow-growing neoplasms like lymphangioleiomyomatosis (LAM) [11] or angiomyolipoma (AML) [12]. Here, TSC1 is linked to lymphangioleiomyomatosis.